Good morning, Boston. Here are the five things you need to know in Boston business news to start your workday.
Takeda Pharmaceutical Co. Ltd. just lost exclusivity on its ADHD drug, thanks to the FDA approving several genetics of Vyvanse, Rowan Walrath reports.
Greg Ryan reports that a Florida-based developer has dropped plans to build hundreds of apartments in the South Shore Plaza’s parking lot after losing a key vote in Braintree.
Start each day with the 5 Things You Need to Know. Sign…
